A newly formed external research advisory committee of nationally known diabetes experts will guide the JDRF on policy matters and research-related issues to help the organization further its strategic plan, according to a press release.
The committee, according to JDRF, will advise the organization on matters of policy pertaining to research philosophy and procedures to help the organization be more effective in its efforts to cure, prevent and treat type 1 diabetes.
PhD, professor in the departments of pathology and pediatrics at the University of Florida, will lead the new committee, which will also include Roy Beck, MD, executive director of the Jaeb Center for Health Research in Tampa, Florida; Matthias Hebrok, PhD, of the University of California, San Francisco; Douglas Melton, PhD, of Harvard University; Lori Laffel MD, MPH, of Harvard University and Joslin Diabetes Center; and Robert Sherwin, MD, of Yale University. Two representatives of JDRF's international board of directors, Stephen Newman, MD, and Margery Perry, will also serve on the committee.
"JDRF is honored to receive support and guidance from such an esteemed group of scientists who are leaders in the type 1 diabetes research field, represent a variety of perspectives, and have long histories with JDRF," Derek Rapp, JDRF president and CEO, said in a press release. "The new research advisory committee will help JDRF work optimally in the interests of the organization, the broader research community, and everyone who shares JDRF's vision of a world without type 1 diabetes."
Besides serving as committee chair, Atkinson, a longtime JDRF volunteer, will act as a senior external adviser to the organization.